Your browser doesn't support javascript.
loading
Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
Takashima, Tsutomu; Kawajiri, Hidemi; Nishimori, Takeo; Tei, Seika; Nishimura, Shigehiko; Yamagata, Shigehito; Tokunaga, Shinya; Mizuyama, Yoko; Sunami, Takeshi; Tezuka, Kenji; Ikeda, Katsumi; Ogawa, Yoshinari; Kashiwagi, Shinichiro; Noda, Satoru; Onoda, Naoyoshi; Ishikawa, Tetsuro; Kudoh, Shinzoh; Takada, Minoru; Hirakawa, Kosei; Ohira, Masaichi.
Afiliación
  • Takashima T; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan tsutomu-@rd5.so-net.ne.jp.
  • Kawajiri H; Department of Breast Surgery, Ishikiri Seiki Hospital, Osaka, Japan.
  • Nishimori T; Department of Surgery, Ikuwakai Memorial Hospital, Osaka, Japan.
  • Tei S; Department of Surgery, Seichokai Fuchu Hospital, Osaka, Japan.
  • Nishimura S; Department of Surgery, Sumitomo Hospital, Osaka, Japan.
  • Yamagata S; Department of Surgery, Seichokai Fuchu Hospital, Osaka, Japan.
  • Tokunaga S; Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Mizuyama Y; Department of Surgery, Ohno Memorial Hospital, Osaka, Japan.
  • Sunami T; Department of Surgery, Izumi Municipal Hospital, Osaka, Japan.
  • Tezuka K; Department of Surgery, Kishiwada City Hospital, Osaka, Japan.
  • Ikeda K; Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Ogawa Y; Department of Breast Surgery, Osaka City General Hospital, Osaka, Japan.
  • Kashiwagi S; Department of Breast Surgery, Osaka City General Hospital, Osaka, Japan.
  • Noda S; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Onoda N; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Ishikawa T; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kudoh S; Department of Surgery, Kashiwara Municipal Hospital, Osaka, Japan.
  • Takada M; Department of Internal Medicine, Osaka Socio-Medical Center Hospital, Osaka, Japan.
  • Hirakawa K; Hanwa Daini Senboku Hospital, Osaka, Japan.
  • Ohira M; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Anticancer Res ; 38(1): 379-383, 2018 01.
Article en En | MEDLINE | ID: mdl-29277798
Asunto(s)
Palabras clave
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paclitaxel / Receptor ErbB-2 / Albúminas / Neoplasias de la Mama Triple Negativas / Paclitaxel Unido a Albúmina / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paclitaxel / Receptor ErbB-2 / Albúminas / Neoplasias de la Mama Triple Negativas / Paclitaxel Unido a Albúmina / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia